Connect
MJA
MJA

Licensing thalidomide in Australia

Martin H N Tattersall
Med J Aust 2004; 180 (4): . || doi: 10.5694/j.1326-5377.2004.tb05878.x
Published online: 16 February 2004

Martin H N Tattersall


  • Australian Drug Evaluation Committee; and Professor of Cancer Medicine, Blackburn Building D06, University of Sydney, Sydney, NSW 2006 


Correspondence: mtatt@med.usyd.edu.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.